Neurofilament: The Journey of a General Marker of Axonal Damage to a Biomarker with Clinical Utility in Multiple Sclerosis & Future Utility in Multiple Indications
- Overview of evidence generation for neurofilament light chain over the last 10 years
- Importance of robust diagnostic testing systems with established performance characteristics for neurofilament testing in clinical trials
- Drug-diagnostic co-development in MS and neurodegenerative disorders